CHEMED CORP (CHE)
Health Care / Health Care Services
S&P MidCap 400$378.85
Below average on several measures. Research carefully.
Weak
Score based on 4 of 5 models — moderate confidence
Is CHEMED CORP a Good Investment in 2026?
CHEMED CORP (CHE) scores 4.1 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates CHEMED CORP as Strong (7/9). The Lynch model is the least favorable, rating it Neutral. CHEMED CORP currently trades below its estimated fair value of $516, suggesting potential upside. CHEMED CORP ranks #816 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Fair value above market price. P/E of 16x is moderate for this quality level.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Neutral
PEG 1.2 · Stalwart
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is CHEMED CORP (CHE) a good investment?
What is CHEMED CORP's Piotroski F-Score?
Is CHE overvalued or undervalued?
How does CHE compare to other Health Care stocks?
What do investment models say about CHE?
Similar Stocks
Compare CHE with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer